Ibaraki, Japan

Akinori Hanatani

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Ibaraki, JP (2009 - 2015)
  • Osaka, JP (2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Akinori Hanatani: Innovator in Transdermal Drug Delivery

Introduction

Akinori Hanatani is a notable inventor based in Ibaraki, Japan. With a strong expertise in pharmaceutical innovations, he holds six patents, particularly focused on enhancing transdermal drug absorption. His inventive work contributes significantly to advancements in drug delivery systems.

Latest Patents

Hanatani's latest patents include compositions aimed at improving the transdermal absorption of drugs, especially acidic drugs. His innovative solutions comprise a combination of unsaturated higher alcohols with a carbon range of 12-20 and polyvalent alcohols with a carbon range of 3-8. Additionally, one of his notable compositions integrates organic amines, broadening the potential applications of his inventions. These formulations are tailored to demonstrate high efficacy in facilitating drug absorption through the skin, which can revolutionize treatment methods.

Career Highlights

Throughout his career, Akinori Hanatani has contributed to leading companies in the industry, including Nitto Denko Corporation and Sasaki Chemical Co., Ltd. His roles in these organizations allowed him to cultivate his background in developing technologies that impact medical and pharmaceutical fields.

Collaborations

Hanatani has collaborated with other accomplished professionals in his field, including Hitoshi Akemi and Yoshihiro Iwao. These partnerships have been instrumental in advancing his research and the practical implementation of his patented formulations.

Conclusion

Akinori Hanatani remains a pivotal figure in the realm of pharmaceutical innovation. His contributions through his patents not only advance the efficacy of drug delivery systems but also pave the way for future advancements in healthcare solutions. His dedication to enhancing transdermal absorption showcases his commitment to improving patient outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…